BioSante Pharmaceuticals, Inc. To Present at Jefferies Global Healthcare Conference

Health and Fitness Health and Fitness

Tue, June 21, 2011

[ Tue, Jun 21st 2011 ] - Market Wire

Impax Laboratories Strengthens Leadership by Addi .. for Global Operations and Global Quality Affairs

[ Tue, Jun 21st 2011 ] - Market Wire

U.S. Supreme Court Declines Life Technologies App .. ement Suit Brought by Enzo Biochem Claiming Subst

[ Tue, Jun 21st 2011 ] - Market Wire

AGA Medical, une filiale de St. Jude Medical, int .. en contrefaon de brevet la?encontre da?Occlutech

[ Tue, Jun 21st 2011 ] - Market Wire

Cambridge Heart Provides Reimbursement Update

[ Tue, Jun 21st 2011 ] - Market Wire

AVEO Pharmaceuticals Announces Closing and Exerci .. Over-Allotment Option for Recent Public Offering

[ Tue, Jun 21st 2011 ] - Market Wire

Compugen Announces Initial Validation of Additional B7/CD28 Protein Family Based Product Candidate

[ Tue, Jun 21st 2011 ] - Market Wire

Kurt May to Join International Stem Cell Corporation as Senior Vice President

[ Tue, Jun 21st 2011 ] - Market Wire

Pfizera?s Lyrica Top-Line Results Positive In Glo .. ral Neuropathic Pain Following Spinal Cord Injury

[ Tue, Jun 21st 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Levofloxacin Oral Solution

[ Tue, Jun 21st 2011 ] - Market Wire

Aethlon Medical to Present at Tomorrow's RedChip Small-Cap Equities Virtual Conference VIII

Mon, June 20, 2011

[ Mon, Jun 20th 2011 ] - Market Wire

Jubilant und Endo Pharmaceuticals melden wichtige .. eue Entdeckungim gemeinsamen Programm gegen Krebs

[ Mon, Jun 20th 2011 ] - Market Wire

Baxter International Inc. Second Quarter 2011 Financial Results Conference Call

[ Mon, Jun 20th 2011 ] - Market Wire

Academy of Wound Technology e KCI annunciano il l .. nentale delle ferite (Transcontinental Wound Regi

[ Mon, Jun 20th 2011 ] - Market Wire

Los datos del estudio de fase II que evala el ben .. Rituximab para pacientes con linfomas de c©lulas

[ Mon, Jun 20th 2011 ] - Market Wire

Five Star Quality Care, Inc. Announces Underwritersa? Exercise of Over-Allotment Option

[ Mon, Jun 20th 2011 ] - Market Wire

Pfizer and Acura Announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII

[ Mon, Jun 20th 2011 ] - Market Wire

Amerinet Signs Agreement with Teleflex Incorporat .. or VasoNova® VPS® (Vascular Positioning System)

[ Mon, Jun 20th 2011 ] - Market Wire

NanoViricides to Lease New Space for cGMP Production

[ Mon, Jun 20th 2011 ] - Market Wire

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

[ Mon, Jun 20th 2011 ] - Market Wire

Perceptive Informatics Brings More Efficiency to .. Development Process With SaaS-Based CTMS Solution

Sun, June 19, 2011

[ Sun, Jun 19th 2011 ] - Market Wire

Gegevens van Fase II klinisch onderzoek wijzen vo .. Rituximab bij patinten met onbehandeld indolent B

[ Sun, Jun 19th 2011 ] - Market Wire

Curis Announces Presentation of Positive Vismodeg .. al Clinical Data in Advanced Basal Cell Carcinoma

Fri, June 17, 2011

[ Fri, Jun 17th 2011 ] - Market Wire

Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer

[ Fri, Jun 17th 2011 ] - Market Wire

Magellan Selects Healthyroads Coaching® to Impro .. kforce Productivity Through Enhanced EAP Services

[ Fri, Jun 17th 2011 ] - Market Wire

REVLIMID® s©lectionn© par GELA, le principal g .. itement des patients adultes atteints de lymphome

[ Fri, Jun 17th 2011 ] - Market Wire

GELA, fhrende Forschungsgemeinschaft fr Lymphomer .. lt REVLIMID® fr umfangreiche Studie fr follikulr

[ Fri, Jun 17th 2011 ] - Market Wire

GELA, the Premier Cooperative Group in Adult Lymp .. REVLIMID® for Major Study in Follicular Lymphoma

[ Fri, Jun 17th 2011 ] - Market Wire

Presentados los datos del estudio de fase I/II qu .. de REVLIMID® en combinacin con la quimioterapia

[ Fri, Jun 17th 2011 ] - Market Wire

Amyris anuncia planos de expanso na sia e na rea .. laborao com a Wilmar, um dos maiores grupos globa

[ Fri, Jun 17th 2011 ] - Market Wire

Fase-2 onderzoek evalueert klinische voordelen va .. uximab om antikankeractiviteit in mantelcellymfoo

[ Fri, Jun 17th 2011 ] - Market Wire

Fase-1/2 gegevens ter evaluatie klinisch voordeel .. et standaard R-CHOP-chemotherapie bij patinten me

[ Fri, Jun 17th 2011 ] - Market Wire

Cord Blood America Acquires Assets of NeoCells, an Illinois Stem Cell Storage Company

Thu, June 16, 2011

[ Thu, Jun 16th 2011 ] - Market Wire

Uno studio di fase II valuta i benefici clinici d .. uximab per migliorare l'attivit anticancerogena n

[ Thu, Jun 16th 2011 ] - Market Wire

Robert S. Vaters Named President and Chief Executive Officer

[ Thu, Jun 16th 2011 ] - Market Wire

International Stem Cell Corporation (ISCO) Announ .. President and CEO of ZO SKIN HEALTH, the Luxury B

[ Thu, Jun 16th 2011 ] - Market Wire

ARIAD Announces Broader Profile of Its Investigat .. date, AP26113, Showing Dual Inhibition of ALK and

[ Thu, Jun 16th 2011 ] - Market Wire

Cubist Announces Positive Results from Two Phase 2 Trials, CXA-201 and CDAD Program

[ Thu, Jun 16th 2011 ] - Market Wire

ZIOPHARM Oncology to Host Analyst & Institutional Investor Meeting on June 23, 2011

[ Thu, Jun 16th 2011 ] - Market Wire

Santarus to Present at the Wells Fargo Securities 2011 Healthcare Conference

[ Thu, Jun 16th 2011 ] - Market Wire

ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise

[ Thu, Jun 16th 2011 ] - Market Wire

Dendreon Announces Webcast Presentation at NASDAQ OMX 26th Investor Program

Wed, June 15, 2011

[ Wed, Jun 15th 2011 ] - Market Wire

MedCath Corporation Adopts Section 382 Rights Plan

[ Wed, Jun 15th 2011 ] - Market Wire

Covidien kndigt Vernderungen im Unternehmen an

[ Wed, Jun 15th 2011 ] - Market Wire

Covidien anuncia mudanas organizacionais

[ Wed, Jun 15th 2011 ] - Market Wire

AVEO Pharmaceuticals Prices Public Offering of Common Stock

[ Wed, Jun 15th 2011 ] - Market Wire

Award of Humana Military TRICARE South Region Contract Upheld

[ Wed, Jun 15th 2011 ] - Market Wire

Alkermes Initiates Clinical Study of ALKS 5461 for Treatment-Resistant Depression

[ Wed, Jun 15th 2011 ] - Market Wire

St. Jude Medical Launches Visualization Tool to Improve EP Lab Workflow

[ Wed, Jun 15th 2011 ] - Market Wire

POZEN to Present at The UBS Specialty Pharmaceuticals Conference

[ Wed, Jun 15th 2011 ] - Market Wire

The Ensign Group, Inc. Declares Quarterly Dividend of $0.055 Per Share

Tue, June 14, 2011

[ Tue, Jun 14th 2011 ] - Market Wire

Dr. Reddya?s Chemical Manufacturing Facility at C .. navaca, Mexico Receives Warning Letter from USFDA

[ Tue, Jun 14th 2011 ] - Market Wire

Bond Labs Reports May Results

[ Tue, Jun 14th 2011 ] - Market Wire

Rotech Healthcare Inc. Announces Registered Exchange Offer for Senior Second Lien Notes due 2018

[ Tue, Jun 14th 2011 ] - Market Wire

Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer

[ Tue, Jun 14th 2011 ] - Market Wire

SANUWAVE Health Wins Patent Challenge

[ Tue, Jun 14th 2011 ] - Market Wire

New Platform to Produce Various Cell Types Free F .. Undifferentiated, Potentially Tumorigenic, Cells

[ Tue, Jun 14th 2011 ] - Market Wire

MedPro Safety Products to Participate in APIC 2011 Annual Educational Conference

[ Tue, Jun 14th 2011 ] - Market Wire

Acento Advertising is Selected as Agency of Choice for Health Net

[ Tue, Jun 14th 2011 ] - Market Wire

Pacira Pharmaceuticals, Inc. Announces FDA Extens .. on of EXPARELa" PDUFA Target Date by Three Months

Mon, June 13, 2011

[ Mon, Jun 13th 2011 ] - Market Wire

Friends of Disabled Adults and Children Partners .. Invacare to Provide Aid in Wake of Joplin Tornado

[ Mon, Jun 13th 2011 ] - Market Wire

Tengion Provides Update on Neo-Urinary Conduit Clinical Trial

[ Mon, Jun 13th 2011 ] - Market Wire

This Fathera?s Day, AstraZeneca Encourages You to .. about Your Cholesterol Level and Atherosclerosis

[ Mon, Jun 13th 2011 ] - Market Wire

Somaxon Completes $5 Million Private Placement of Equity to Paladin Labs Inc.

[ Mon, Jun 13th 2011 ] - Market Wire

Cosan and Amyris Forming Novvi S.A. for Global Pr .. tion and Commercialization of Renewable Base Oils

[ Mon, Jun 13th 2011 ] - Market Wire

Amyris e Cosan formam Novvi S.A. para Produo e Comercializao Globais de "leos de Base Renovvel

[ Mon, Jun 13th 2011 ] - Market Wire

Emergent BioSolutions Chairman and CEO Fuad El-Hi .. ed to U.S. Chamber of Commerce Board of Directors

[ Mon, Jun 13th 2011 ] - Market Wire

Vertex and Alios BioPharma Announce Exclusive Wor .. r Two Nucleotide Drug Candidates, Broadening Vert

[ Mon, Jun 13th 2011 ] - Market Wire

Magellan Health Services Announces Extension of Maricopa County, Arizona Medicaid Contract

Fri, June 10, 2011

[ Fri, Jun 10th 2011 ] - Market Wire

Tibet Pharmaceuticals Announces New CEO

[ Fri, Jun 10th 2011 ] - Market Wire

Millennium and Seattle Genetics Present Clinical .. ab Vedotin) in Systemic ALCL at EHA Annual Meetin

[ Fri, Jun 10th 2011 ] - Market Wire

A.M. Best Assigns Ratings to Coventry Health Care Inc.a?s New Senior Unsecured Notes

[ Fri, Jun 10th 2011 ] - Market Wire

Northwest Biotherapeutics kndigt Wechsel und Erweiterungen in der Geschftsleitung an

[ Fri, Jun 10th 2011 ] - Market Wire

Positron Executes Memorandum of Understanding wit .. lle, Indiana; Economic Incentives for Development

[ Fri, Jun 10th 2011 ] - Market Wire

ARIAD to Host Analyst & Investor Day in New York City

[ Fri, Jun 10th 2011 ] - Market Wire

Enzo Biochema?s Clinical Lab Acquires Marketing R .. ore Effective Diagnostic Test for Cervical Cancer

[ Fri, Jun 10th 2011 ] - Market Wire

Centric Health Reports First Quarter Results

[ Fri, Jun 10th 2011 ] - Market Wire

ZIOPHARM Oncology Announces Acceptance of Investi .. for ZIN ATI-001 (Ad-RTS-IL-12), a Novel DNA-Base

Thu, June 9, 2011

[ Thu, Jun 09th 2011 ] - Market Wire

Medisafe 1 Technologies in Negotiations to Acquire Breakthrough Dental Implant Technology

[ Thu, Jun 09th 2011 ] - Market Wire

LifeVantage Corporation to Present at Accredited .. embers Summer 2011 Investment Research Conference

[ Thu, Jun 09th 2011 ] - Market Wire

Galectin Therapeutics to Present Corporate Update at NIBA Conference

[ Thu, Jun 09th 2011 ] - Market Wire

Gallup and Healthways Release May 2011 Well-Being Index Report

[ Thu, Jun 09th 2011 ] - Market Wire

Centric Health Completes Acquisition of LifeMark Health

[ Thu, Jun 09th 2011 ] - Market Wire

SONOMAX® TECHNOLOGIES ANNUAL GENERAL MEETING

[ Thu, Jun 09th 2011 ] - Market Wire

PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million

[ Thu, Jun 09th 2011 ] - Market Wire

Inovio Pharmaceuticals Subsidiary, VGX Animal Hea .. resent at VetHealth Global 2011, June 14-17, 2011

[ Thu, Jun 09th 2011 ] - Market Wire

Brookdale Announces Pricing of $275 Million of Convertible Senior Notes Due 2018

Wed, June 8, 2011

[ Wed, Jun 08th 2011 ] - Market Wire

2011 FIRST QUARTER FINANCIAL RESULTS

[ Wed, Jun 08th 2011 ] - Market Wire

Healthways SilverSneakers Fitness Program Now Ava .. Wisconsina?s Largest Medicare Supplement Program

[ Wed, Jun 08th 2011 ] - Market Wire

Neurologix Presents New Confirmatory Results for .. Parkinson's Disease to Recombinant DNA Advisory C

[ Wed, Jun 08th 2011 ] - Market Wire

Biogen Idec obtiene aprobacin en la Unin Europea para AVONEX® PEN TM

[ Wed, Jun 08th 2011 ] - Market Wire

Biogen Idec ontvangt in de Europese Unie goedkeuring voor AVONEX® PENa"

[ Wed, Jun 08th 2011 ] - Market Wire

Revoici la d©pche corrig©e: Biogen Idec obtient .. dans la?Union Europ©enne pour la?AVONEX® PENa"

[ Wed, Jun 08th 2011 ] - Market Wire

Biogen Idec ottiene l'approvazione nell'Unione Europea per l'AVONEX® PENa"

[ Wed, Jun 08th 2011 ] - Market Wire

Alnylam Provides Organizational Update

[ Wed, Jun 08th 2011 ] - Market Wire

Synergetics Reports Record Sales and Operating Income for Third Quarter

Tue, June 7, 2011

[ Tue, Jun 07th 2011 ] - Market Wire

Roche and Merck Collaborate to Develop Diagnostic .. sts for Mercka?s Investigational Cancer Therapies

[ Tue, Jun 07th 2011 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present at Jefferies Global Healthcare Conference

[ Tue, Jun 07th 2011 ] - Market Wire

Nordion Declares Quarterly Dividend of US $0.10 per Share

[ Tue, Jun 07th 2011 ] - Market Wire

Aethlon Medical to Discuss Recent Progress at the .. edical Technologies Virtual Conference on June 16

[ Tue, Jun 07th 2011 ] - Market Wire

Cumberland Pharmaceuticals to Present at the 2011 .. Fargo Securities Healthcare Conference in Boston

[ Tue, Jun 07th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Is Investigating Eli Lilly & Co. - LLY

[ Tue, Jun 07th 2011 ] - Market Wire

Alexion to Present at the 31st Annual William Blair & Company Growth Stock Conference

[ Tue, Jun 07th 2011 ] - Market Wire

OncoSec ElectroImmunotherapy Shows Systemic Effec .. tatic Melanoma Tumor in More than 50% of Patients

Mon, June 6, 2011

[ Mon, Jun 06th 2011 ] - Market Wire

Exelixisa? Cabozantinib Phase 2 Data Demonstrate .. in Patients with Metastatic Castration-Resistant

[ Mon, Jun 06th 2011 ] - Market Wire

Emergent BioSolutions Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX BioPharma

[ Mon, Jun 06th 2011 ] - Market Wire

New Clinical Data Analysis of AMPYRA® (Dalfampri .. ient-Reported Walking Ability across a Range of W

[ Mon, Jun 06th 2011 ] - Market Wire

MedPro Safety Products Announces Availability of Crystal Research Associates Report

[ Mon, Jun 06th 2011 ] - Market Wire

Presentati all'ASCO i dati finali di fase III del .. ® in combinazione col carboplatino in pazienti a

[ Mon, Jun 06th 2011 ] - Market Wire

ImmunoGen, Inc. Announces Positive Clinical Data .. d on IMGN901 in the Treatment of Multiple Myeloma

[ Mon, Jun 06th 2011 ] - Market Wire

Exelixisa? Cabozantinib Demonstrates Broad Clinical Activity in Multiple Tumor Types

[ Mon, Jun 06th 2011 ] - Market Wire

Phase II Study Evaluates Clinical Benefit of REVL .. for Patients with Metastatic Castration-Resistant

[ Mon, Jun 06th 2011 ] - Market Wire

Uno studio di fase II valuta i benefici clinici d .. LIMID® sui pazienti affetti da cancro prostatico

Sat, June 4, 2011

[ Sat, Jun 04th 2011 ] - Market Wire

Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims

[ Sat, Jun 04th 2011 ] - Market Wire

ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO

[ Sat, Jun 04th 2011 ] - Market Wire

Sanofi's Investigational Semuloparin in Cancer Pa .. py Shows a 64% Risk Reduction in Life-Threatening

Fri, June 3, 2011

[ Fri, Jun 03rd 2011 ] - Market Wire

Impax Laboratories Confirms Patent Suit Relating .. Detrol® Immediate-Release 1 mg and 2 mg Tablets

[ Fri, Jun 03rd 2011 ] - Market Wire

Covidien annonce la?obtention de la?autorisation .. robation de la marque europ©enne CE pour sa mail

[ Fri, Jun 03rd 2011 ] - Market Wire

Medtronic CFO Gary Ellis to Speak at Goldman Sachs Healthcare Conference

[ Fri, Jun 03rd 2011 ] - Market Wire

Impax Laboratories to Present at the Jefferies 2011 Global Healthcare Conference

[ Fri, Jun 03rd 2011 ] - Market Wire

Ligand and The Medicines Company Agree to Worldwi .. tisol®-Enabled Intravenous Formulation of Clopid

[ Fri, Jun 03rd 2011 ] - Market Wire

Cardiovascular Systems Announces Filing of Universal Shelf Registration Statement

[ Fri, Jun 03rd 2011 ] - Market Wire

Five Star Quality Care, Inc. to Present at the Je .. 2011 Global Healthcare Conference on June 9, 2011

[ Fri, Jun 03rd 2011 ] - Market Wire

Medisafe 1 Technologies Announces Three Medical Device Patent Filings

[ Fri, Jun 03rd 2011 ] - Market Wire

LifeVantage's Nrf2 Activator Reviewed for Tumor P .. tion and Suppression in New Peer-Reviewed Article

Thu, June 2, 2011

[ Thu, Jun 02nd 2011 ] - Market Wire

Teva Completes Enrollment in Phase III Multiple S .. Evaluating Glatiramer Acetate Three Times Weekly

[ Thu, Jun 02nd 2011 ] - Market Wire

Final Analysis from AVEO Pharmaceuticalsa? Phase .. ents with Advanced Renal Cell Carcinoma Presented

[ Thu, Jun 02nd 2011 ] - Market Wire

Continucare Corporation to Present at the Jefferies 2011 Global Healthcare Conference

[ Thu, Jun 02nd 2011 ] - Market Wire

Galectin Therapeutics Announces the Appointment o .. reeman and John Mauldin to the Board of Directors

[ Thu, Jun 02nd 2011 ] - Market Wire

Covidien meldet US-Zulassung im 510(k)-Verfahren .. -Kennzeichnung fr Parietexa" Optimized Composite-

[ Thu, Jun 02nd 2011 ] - Market Wire

Nordion Builds North America';s First Food-Only Gamma Irradiator

[ Thu, Jun 02nd 2011 ] - Market Wire

MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. ent at Jeffries 2011 Global Healthcare Conference

[ Thu, Jun 02nd 2011 ] - Market Wire

PROTOX REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS AND ACHIEVEMENTS

[ Thu, Jun 02nd 2011 ] - Market Wire

OncoSec Medical Clinical Adviser Will Present Ele .. m Melanoma Clinical Trial at 2011 ASCO Annual Mee

Wed, June 1, 2011

[ Wed, Jun 01st 2011 ] - Market Wire

Biogen Idec to Present at the Jefferies 2011 Global Healthcare Conference

[ Wed, Jun 01st 2011 ] - Market Wire

Dyax Corp. to Present at the Jefferies Global Healthcare Conference

[ Wed, Jun 01st 2011 ] - Market Wire

Tenet Management to Present at Jefferies 2011 Global Healthcare Conference on June 6th

[ Wed, Jun 01st 2011 ] - Market Wire

HealthSpring, Inc. to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference

[ Wed, Jun 01st 2011 ] - Market Wire

Celldex Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference

[ Wed, Jun 01st 2011 ] - Market Wire

AlphaRx Terminates Its Chief Scientist and Chief Medical Officer for Cause

[ Wed, Jun 01st 2011 ] - Market Wire

Caerus Discovery, LLC a" A New Biotechnology Company is Announced

[ Wed, Jun 01st 2011 ] - Market Wire

BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market

[ Wed, Jun 01st 2011 ] - Market Wire

Health Management Associates, Inc. to Present at .. an Sachs 32nd Annual Global Healthcare Conference

Tue, May 31, 2011

[ Tue, May 31st 2011 ] - Market Wire

HealthSpring, Inc. to Present at the Jefferies 2011 Global Healthcare Conference

[ Tue, May 31st 2011 ] - Market Wire

Healthways Announces Election of Chairman of the Board, John Ballantine

[ Tue, May 31st 2011 ] - Market Wire

BioSante Pharmaceuticals Completes Enrollment in LibiGel® Phase III Safety Study

[ Tue, May 31st 2011 ] - Market Wire

Stockholders Approve All Proposals at Galectin Therapeuticsa? Annual Stockholders Meeting

[ Tue, May 31st 2011 ] - Market Wire

YM BioSciences Announces Orphan Drug Designation for JAK1/JAK2 Inhibitor CYT387 in Europe

[ Tue, May 31st 2011 ] - Market Wire

Spectranetics Introduces First Advanced System fo .. lation of Peripheral Vascular Arterial Occlusions

[ Tue, May 31st 2011 ] - Market Wire

ENZON Names Ana I. Stancic Chief Financial Officer

[ Tue, May 31st 2011 ] - Market Wire

ZIOPHARM to Present at the Jefferies 2011 Global Healthcare Conference

[ Tue, May 31st 2011 ] - Market Wire

Affymax and Takeda Announce the Submission of a N .. esatide for the Treatment of Anemia Associated wi

Mon, May 30, 2011

[ Mon, May 30th 2011 ] - Market Wire

MEDWELL CAPITAL REPORTS FIRST QUARTER 2011 RESULTS

[ Mon, May 30th 2011 ] - Market Wire

Salix Pharmaceuticals to Present at Three Investment Conferences in June

Fri, May 27, 2011

[ Fri, May 27th 2011 ] - Market Wire

Curis to Present at the Jefferies 2011 Global Healthcare Conference

[ Fri, May 27th 2011 ] - Market Wire

Universal American Corp. to Present at the Jeffer .. Global Healthcare Conference on Monday, June 6th

[ Fri, May 27th 2011 ] - Market Wire

Millennium and Seattle Genetics Announce Brentuxi .. tions at 16th Congress of the European Hematology

[ Fri, May 27th 2011 ] - Market Wire

InSite Vision to Webcast Annual Meeting of Stockholders on June 1, 2011

[ Fri, May 27th 2011 ] - Market Wire

Roche Signs Exclusive Agreement with IT-IS Life S .. cler® Nano Instrument for Low-Throughput qPCR Ma

[ Fri, May 27th 2011 ] - Market Wire

BURCON TO PRESENT AT 13th INTERNATIONAL RAPESEED CONGRESS

[ Fri, May 27th 2011 ] - Market Wire

AVEO Pharmaceuticals, Inc. to Present at the Jefferies 2011 Global Healthcare Conference

Thu, May 26, 2011

[ Thu, May 26th 2011 ] - Market Wire

NUVO RESEARCH ANNOUNCES 2011 FIRST QUARTER RESULTS

[ Thu, May 26th 2011 ] - Market Wire

Launch Expected in Fourth Quarter 2011

[ Thu, May 26th 2011 ] - Market Wire

Health Net Announces Appearance at Sanford C. Bernstein Conference

[ Thu, May 26th 2011 ] - Market Wire

ARCA biopharma Announces Planned Expansion of Gencaro Development to Atrial Fibrillation

[ Thu, May 26th 2011 ] - Market Wire

Akorn Announces Pricing of $100 Million of Convertible Senior Notes Due 2016

[ Thu, May 26th 2011 ] - Market Wire

BioCryst Presents New Analyses of BCX4208 Phase 2 .. t at the Annual European Congress of Rheumatology

[ Thu, May 26th 2011 ] - Market Wire

Healthways Signs Services Agreement with HP to Support Company Growth

[ Thu, May 26th 2011 ] - Market Wire

Sequenom Announces Participation at Jefferies 2011 Global Healthcare Conference

[ Thu, May 26th 2011 ] - Market Wire

OncoSec Medical to Initiate Multiple Phase II Skin Cancer Clinical Trials

Wed, May 25, 2011

[ Wed, May 25th 2011 ] - Market Wire

Aetna Ranked Tops in Connecting with Doctors

[ Wed, May 25th 2011 ] - Market Wire

International Stem Cell Corporation Reports First .. ion on Strong Initial Sales of Skin Care Products

[ Wed, May 25th 2011 ] - Market Wire

Biogen Idec celebra el da mundial de la esclerosis mltiple

[ Wed, May 25th 2011 ] - Market Wire

Derma Sciences Reports Continued Healing at 24 We .. Foot Ulcers Treated with DSC127 in Phase 2 Trial

[ Wed, May 25th 2011 ] - Market Wire

UnitedHealth Group Board Increases Shareholder Di .. idend; Renews, Increases Share Repurchase Program

[ Wed, May 25th 2011 ] - Market Wire

Biogen Idec c©lbre la Journ©e mondiale de la scl©rose en plaques

[ Wed, May 25th 2011 ] - Market Wire

IMAGING DYNAMICS ANNOUNCES CHANGES TO THE BOARD OF DIRECTORS

[ Wed, May 25th 2011 ] - Market Wire

Synergetics USA, Inc. to Hold Investor Meetings with Craig-Hallum Capital Group

[ Wed, May 25th 2011 ] - Market Wire

Biogen Idec celebra la giornata mondiale della SM

Tue, May 24, 2011

[ Tue, May 24th 2011 ] - Market Wire

Pfizer Announces Detailed Results Of ORAL Sync Sh .. d Tofacitinib Reduces Signs And Symptoms And Impr

[ Tue, May 24th 2011 ] - Market Wire

Centric Health Announces Investor Day Event

[ Tue, May 24th 2011 ] - Market Wire

Derma Sciences to Hold Conference Call Tomorrow, .. a from Phase 2 DSC127 Trial in Diabetic Foot Ulce

[ Tue, May 24th 2011 ] - Market Wire

Cannabis Science Negotiates Several Commercializa .. ancer Cannabis Formulations Available To The Publ

[ Tue, May 24th 2011 ] - Market Wire

Merck Announces Third Quarter 2011 Dividend

[ Tue, May 24th 2011 ] - Market Wire

Bond Labs Reports Strong April Results; Extends Impressive Growth Trend

[ Tue, May 24th 2011 ] - Market Wire

Medtronic Provides Initial Revenue Outlook and EPS Guidance for Fiscal Year 2012

[ Tue, May 24th 2011 ] - Market Wire

ImmunoCellular Therapeutics to Present New Data f .. f ICT-107 in Glioblastoma Multiforme at ASCO 2011

[ Tue, May 24th 2011 ] - Market Wire

Biogen Idec Launches Women in MS Educational Initiative

Mon, May 23, 2011

[ Mon, May 23rd 2011 ] - Market Wire

Data From a Phase 1 Clinical Trial of Exelixisa? .. nib Published in the Journal of Clinical Oncology

[ Mon, May 23rd 2011 ] - Market Wire

AmSurg Names Veteran Healthcare Executive Cindy Miller to Board of Directors

[ Mon, May 23rd 2011 ] - Market Wire

Covidien introduceert middel voor naleving Consci .. llaboration voor professionals in gezondheidszorg

[ Mon, May 23rd 2011 ] - Market Wire

Ragweed and Mold Lead Overall Upswing in Allergy Prevalence; Climate Change Suspected

[ Mon, May 23rd 2011 ] - Market Wire

FDA Approves INCIVEKa" (telaprevir) for People with Hepatitis C

[ Mon, May 23rd 2011 ] - Market Wire

Micromet to Report Blinatumomab Data at June Medical Conferences

[ Mon, May 23rd 2011 ] - Market Wire

Synergetics USA Announces Conference Call to Review Third Quarter of Fiscal Year 2011 Results

[ Mon, May 23rd 2011 ] - Market Wire

BCBSNC to Offer Healthways SilverSneakers® to Blue Medicare Supplement Members

[ Mon, May 23rd 2011 ] - Market Wire

Santarus Announces Presentation of RHUCIN Clinical Data at 7th C1 Inhibitor Deficiency Workshop

Sun, May 22, 2011

[ Sun, May 22nd 2011 ] - Market Wire

St. Jude Medical maakt lancering van het nieuwste .. imulatieleidingen voor chronische pijn op de Aust

[ Sun, May 22nd 2011 ] - Market Wire

St. Jude Medical kndigt Markteinfhrung in Austral .. eitereinfhrsystem fr die Neurostimulation zur Beh

[ Sun, May 22nd 2011 ] - Market Wire

St. Jude Medical annonce le lancement sur le marc .. a?introduction da?©lectrodes de neurostimulation

[ Sun, May 22nd 2011 ] - Market Wire

St. Jude Medical annuncia il lancio sul mercato a .. o nel suo genere per la?impianto di elettrodi neu

BioSante Pharmaceuticals, Inc. To Present at Jefferies Global Healthcare Conference

_{//health-fitness.news-articles.net/content/2011/ .. t-at-jefferies-global-healthcare-conference.html}
^{Published in Health and Fitness on Wednesday, June 8th 2011 at 2:01 GMT by Market Wire}

LINCOLNSHIRE, Ill.--([ BUSINESS WIRE ])--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Phillip B. Donenberg, BioSantea�s senior vice president of finance and CFO, will speak on Thursday, June 9, 2011 at 4:00pm eastern time at the Jefferies 2011 Global Healthcare Conference at the Grand Hyatt Hotel in New York City.

Mr. Donenberg will provide an overview of BioSante, as well as an update on the LibiGel^� (testosterone gel) Phase III clinical development program.

About BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSantea�s lead products include LibiGel^� (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSantea�s first FDA-approved product is Elestrina" (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSantea�s licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gela", a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: [ www.biosantepharma.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire